ZLD 27.8% 46.0¢ zelira therapeutics limited

Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-50

  1. 9,103 Posts.
    lightbulb Created with Sketch. 511
    Are you kidding me!

    so low Soi and mc

    well done you holders

    multiples from here no advice !

    Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a global leader in the research, development, and commercialisation of clinically validated cannabinoid medicines, is pleased to announcethat its diabetic nerve pain drug outperformed in a clinical trial against a multi-billion-dollar Big Pharmaceutical company drug Lyrica.®
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.